Cecilia Monge

1.3k total citations · 1 hit paper
30 papers, 745 citations indexed

About

Cecilia Monge is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Cecilia Monge has authored 30 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Cecilia Monge's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Cecilia Monge is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Cecilia Monge collaborates with scholars based in United States, Malaysia and Australia. Cecilia Monge's co-authors include Joseph Clara, Yingzi Yang, Naoko Takebe, Tim F. Greten, Changqing Xie, Seth M. Steinberg, Bradford J. Wood, Bernadette Redd, Francisco Carranza and David E. Kleiner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Cecilia Monge

27 papers receiving 743 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update

2019 538 citations Joseph Clara, Cecilia Monge et al. Nature Reviews Clinical Oncology profile →

Peers

Cecilia Monge

ONCOL

IMMUN

PRM

Paola Bianca Italy

Leilei Tao China

Tadahito Yasuda Japan

Hiroaki Kasashima Japan

Katsuharu Saito Japan

Joseph Clara United States

Zhefang Wang Germany

Tianhong Su China

Cuiju Tang China

Aleksandra Markiewicz Poland

Paola Bianca Italy

Cecilia Monge

322 ×0.8

ONCOL

341 ×1.0

204 ×0.9

117 ×0.9

IMMUN

105 ×0.9

PRM

Citations per year, relative to Cecilia Monge Cecilia Monge (= 1×) peers Paola Bianca

Countries citing papers authored by Cecilia Monge

Since Specialization

Citations

This map shows the geographic impact of Cecilia Monge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Monge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Monge more than expected).

Fields of papers citing papers by Cecilia Monge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Monge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Monge. The network helps show where Cecilia Monge may publish in the future.

Co-authorship network of co-authors of Cecilia Monge

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Monge. A scholar is included among the top collaborators of Cecilia Monge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Monge. Cecilia Monge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monge, Cecilia, et al.. (2025). Detecting PI3K and TP53 Pathway Disruptions in Early‐Onset Colorectal Cancer Among Hispanic/Latino Patients. Cancer Medicine. 14(7). e70791–e70791. 8 indexed citations

Monge, Cecilia, et al.. (2025). Pathway-Specific Genomic Alterations in Pancreatic Cancer Across Populations at Risk. International Journal of Molecular Sciences. 26(16). 7695–7695.

Monge, Cecilia, C Larraín, Lindsay Friedman, et al.. (2025). Hepatic lymph node metastases predict survival for patients undergoing HAIP therapy for CRLM. HPB. 27. S78–S78.

Monge, Cecilia, et al.. (2025). Molecular Alterations in TP53, WNT, PI3K, TGF-Beta, and RTK/RAS Pathways in Gastric Cancer Among Ethnically Heterogeneous Cohorts. Cancers. 17(7). 1075–1075. 2 indexed citations

Ruíz‐García, Erika, et al.. (2025). Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer. Clinical & Translational Oncology. 27(12). 4342–4358.

Monge, Cecilia, et al.. (2025). Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers. 17(7). 1093–1093. 3 indexed citations

Greten, Tim F., et al.. (2025). Disparities in Cholangiocarcinoma Research and Trials: Challenges and Opportunities in the United States. JCO Global Oncology. 11(11). e2400537–e2400537. 1 indexed citations

Greten, Tim F., et al.. (2024). Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States. Journal of Racial and Ethnic Health Disparities. 12(6). 3793–3804. 4 indexed citations

Monge, Cecilia, Changqing Xie, Yuta Myojin, et al.. (2024). Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer Medicine. 13(3). e6912–e6912. 6 indexed citations

10.

Wang, Limin, Marshonna Forgues, Shay Behrens, et al.. (2024). Lineage and ecology define liver tumor evolution in response to treatment. Cell Reports Medicine. 5(2). 101394–101394. 3 indexed citations

11.

Myojin, Yuta, Cecilia Monge, Changqing Xie, et al.. (2024). VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for ImmunoTherapy of Cancer. 12(1). e008079–e008079. 7 indexed citations

12.

Monge, Cecilia, Changqing Xie, Yuta Myojin, et al.. (2023). Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(2). e005640–e005640. 46 indexed citations

13.

Monge, Cecilia & Tim F. Greten. (2023). Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer Medicine. 13(1). e6814–e6814. 10 indexed citations

14.

Xie, Changqing, et al.. (2023). The current landscape of therapies for hepatocellular carcinoma. Carcinogenesis. 44(7). 537–548. 14 indexed citations

15.

Monge, Cecilia, et al.. (2023). Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States. Journal of Hepatocellular Carcinoma. Volume 10. 1223–1235. 7 indexed citations

16.

Monge, Cecilia, Erica C. Pehrsson, Changqing Xie, et al.. (2022). A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The Oncologist. 27(3). e273–e285. 32 indexed citations

17.

Mena, Esther, Joanna H. Shih, Joon‐Yong Chung, et al.. (2022). Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma. PLoS ONE. 17(11). e0277407–e0277407. 5 indexed citations

18.

Clara, Joseph, Cecilia Monge, Yingzi Yang, & Naoko Takebe. (2019). Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update. Nature Reviews Clinical Oncology. 17(4). 204–232. 538 indexed citations breakdown →

19.

Monge, Cecilia, Hoyoung Maeng, Alessandra Brofferio, et al.. (2018). Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report. Journal for ImmunoTherapy of Cancer. 6(1). 150–150. 24 indexed citations

20.

Cooper, Howard A., Cecilia Monge, & Julio A. Panza. (2008). Patients with end-stage renal disease and acute myocardial infarction have poor short-term outcomes despite modern cardiac intensive care. Coronary Artery Disease. 19(4). 231–235. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact